Free shipping on all products. Track your order on the Order Status & Details page.
🇦🇺 Australian-Owned Supplier  ·  Janoshik Verified  ·  Wholesale Pricing

Buy MOTS-C in Australia

MC10 — 10mg per vial, box of 10 research-grade vials. Mitochondria-encoded 16-AA peptide from the 12S rRNA ORF, translocates to nucleus under metabolic stress, activates AMPK. Insulin sensitivity and mitochondrial biogenesis research. See published product reports for batch-specific testing information. Australian-based online distributor. For research use only.

View Products and Pricing Compare with IGF-1 LR3
Research Use Only: All products are for qualified laboratory research purposes only — not for human therapeutic use or consumption. Subject to applicable Australian regulatory requirements.

What Is MOTS-C?

MOTS-C (Mitochondrial ORF of the Twelve S rRNA type-C) is a 16-amino-acid peptide (MRWQEMGYIFYPRKLR) encoded by a small open reading frame within the mitochondrial 12S ribosomal RNA gene. Its discovery established a new class of mitochondria-derived signalling peptides — distinct from nuclear-encoded mitochondrial proteins. Under metabolic stress (glucose limitation, oxidative stress), MOTS-C translocates from the mitochondria to the cytoplasm and subsequently to the nucleus, where it modulates adaptive gene expression programs.

The primary metabolic mechanism involves MOTS-C's inhibition of the folate-methionine cycle, leading to accumulation of the AMPK activator AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), which promotes AMPK phosphorylation at Thr172. Activated AMPK drives glucose transporter GLUT4 translocation to the plasma membrane (increasing glucose uptake), suppresses mTORC1-mediated anabolic pathways, and stimulates PGC-1α-dependent mitochondrial biogenesis. Research models have utilised MOTS-C to study insulin sensitisation, exercise-mimetic effects, metabolic adaptation to stress, and age-associated metabolic decline.

For downstream IGF-1 axis research, see IGF-1 LR3 (IG10). For upstream GHRH-axis GH stimulation, see Sermorelin (SMO5 / SMO10). For research use only.

MOTS-C Products

Supplied as lyophilised powder in boxes of 10 research-grade vials.

MC10

MOTS-C 10mg

Box of 10 vials · 10mg per vial

$495.00 per box
  • ✓ Janoshik COA published on product page
  • ✓ Review batch-specific test results
  • ✓ Free shipping
  • ✓ View available reports on the product pages
View product page & COA

Quality Assurance

🔬
HPLC Purity
Published HPLC reports identify the submitted sample and measured purity
⚗️
Mass Spectrometry
MS confirmation of 16-AA sequence and molecular weight
🧫
Sterility + Endotoxin
See the product reports for TAMC/TYMC microbial screening and endotoxin results
📄
COA Published
Certificate of Analysis verifiable at janoshik.com, included with order

Frequently Asked Questions

Where can I buy MOTS-C in Australia?

Eternal Peptides Wholesale is an Australian-based online wholesale distributor. MC10 (MOTS-C 10mg, box of 10) is $495.00. Check the product page for available batch reports. Consult our Shipping Policy for processing and delivery estimates. Dispatch origin can vary, including offshore fulfilment; Australian business ownership does not guarantee domestic stock or customs-free delivery. For research use only.

What makes MOTS-C unique compared to other peptides?

Most research peptides are nuclear-encoded proteins targeted to various cellular compartments. MOTS-C is one of a very small class of peptides directly encoded in the mitochondrial genome — specifically within the 12S rRNA gene. This makes it part of a mitochondria-to-nucleus communication axis and positions it as a metabolic stress signal produced at the site of cellular energy production. For research use only.

How does MOTS-C activate AMPK?

MOTS-C inhibits MTHFD1L in the folate cycle, reducing AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) conversion and causing its accumulation. AICAR is a well-characterised AMPK activator — it mimics AMP and activates AMPK allosterically, promoting Thr172 phosphorylation. AMPK activation then drives glucose uptake (GLUT4 translocation), inhibits mTOR, and stimulates mitochondrial biogenesis via PGC-1α. For research use only.

How is MOTS-C tested?

Review the published reports for the selected product and batch. Only the tests and results shown on those reports apply; do not assume additional methods or testing were performed.

Related Research Pages

Buy IGF-1 LR3 Australia Buy Sermorelin Australia Buy Tesamorelin Australia Buy BPC-157 Australia

Research and buying guide

Testing and wholesale procurement: source notes

Assess purity separately from peptide quantity. Bachem explains that HPLC purity and net peptide content describe different properties. For an EPW procurement review, start with the published report directory, then match the product, strength and batch to the documents. [1] [2]

Our testing programme addresses purity, endotoxins, sterility testing (TAMC/TYMC microbial screening) and heavy metals. Janoshik describes the microbial, endotoxin and metals analyses as separate services; the actual report determines the tests and results applicable to a sample. A general programme description is not a claim that every item has all four reports. [3] [4] [5]

For wholesale value, compare the same specification and quantity, then check the total payable. The wholesale-price guide explains the method. Reports do not establish therapeutic approval or a legal exemption; the TGA explains that research-use wording alone does not remove applicable obligations. [6] [7]

References and bibliography

  1. Bachem. FAQ: analysis of peptides, HPLC purity and net peptide content. Accessed 29 September 2026.
  2. Eternal Peptides Wholesale. Published product-report directory. Accessed 29 September 2026.
  3. Janoshik Analytical. Sterility testing (TAMC+TYMC): method and scope. Accessed 29 September 2026.
  4. Janoshik Analytical. Endotoxin analysis: LAL assay and reporting units. Accessed 29 September 2026.
  5. Janoshik Analytical. Heavy metals screening (As, Cd, Pb, Hg). Accessed 29 September 2026.
  6. Australian Competition and Consumer Commission. Price displays. Accessed 29 September 2026.
  7. Therapeutic Goods Administration. How we regulate therapeutic peptide products. Accessed 29 September 2026.